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Certainly the most common type of tissue injury to the body involves the 
almost daily insults  induced nonspecifically by mechanical means.  Tissue in- 
jury, whether it be in the form of an abrasion, a laceration, or a large area of 
severely damaged tissue,  almost invariably is associated with the onset of the 
acute  inflammatory  response,  which  not  only  provides  a  protective  shield 
against infection but also marks the first in a  series  of events leading to the 
intricate process of healing.  The reason for the development of the acute in- 
flammatory response under such conditions is completely obscure. 
Hurley in 1964 presented evidence that when various tissues of the rat were 
minced and  individually incubated  with  rat  serum,  a  factor chemotactic for 
neutrophilic granulocytes appeared (1). He postulated that the interaction of a 
substance in tissue with a factor in serum resulted in the generation of a chemo- 
tactic  product,  the  nature  of  which  was not  defined.  The  following studies 
indicate that many tissues of the rat contain a protease, trypsin-like in nature, 
which  can  cleave the  third  component of complement  (C'3)  into chemotac- 
tically active fragments. Not only does this provide a possible explanation for 
the pathogenesis of the acute inflammatory response to injured tissue,  but it 
emphasizes once again a  role for the complement system in the generation by 
nonimmunological means of phlogistic factors capable of triggering the acute 
inflammatory response. 
Materials and Methods 
Chemotaxis.--The micropore filter method was used, with chambers that have been de- 
scribed previously (2). Rabbit neutrophils from a glycogen-induced peritoneal exudate were 
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employed.  The  "Principles of Laboratory Animal Care"  as  promulgated  by  the National 
Society for Medical Research were observed during this study. 
Tissue Minces.--150  g  adult male Wistar rats were anesthetized with ether and exsan- 
guinated from the inferior vena cava. Wet fragments of various organs or tissues were rinsed 
in saline, weighed, and diced with a razor blade on a glass plate. Unless otherwise indicated, 
tissue minces were incubated in saline, fresh rat serum, or preparations of purified human 
complement components for the appropriate interval of time at 37°C.  The tissue was then 
removed by centrifugation, and the supernatant was tested for chemotactic activity. 
Complement PreparoZions.--Preparations of highly purified human complement consisting 
of the third  (file-globulin or C3)  and fifth (/51F-globulin or C5)  components were obtained 
according to the methods of Nllsson and Miiller-Eberhard (3).  Antibody to rat C3 (anti-C3 
or anti-file) was obtained by appropriate immunization of rabbits (4). Rat serum was treated 
with KSCN according to the method of Dalmasso and Mifller-Eberhard (5) in order to deplete 
C3 and  C5 activity. When ethylenediaminetetmacetate (EDTA)  (Aldrich Chemical Co., St. 
Louis, Me.) was employed, appropriate dilutions were made from a 0.02 ~t stock solution, pH 
7.3. 
Ultracentrifugal Analysis.--Purified  human C3 treated with heart tissue was analyzed by 
ultracentrifugation in a  sucrose density gradient.  Centrifugation was performed  at  55,000 
rpm for 15 hr (4°C) in sucrose (5-350/0) dissolved in phosphate buffer (pH 7.3, ionic strength 
0.05). Details of this procedure are described elsewhere (2, 6). 
Gd Filtration.--The  same tissue-treated C3 preparation used for density gradient analysis 
was also eluted from Sephadex G-75  (Pharmacia, Piscataway, N.J.)  with phosphate buffer 
(pH 7.3, ionic strength 0.05), and the fractions were scanned for chemotactic activity. Protein 
or peptide markers in the density gradients included bovine serum albumin, cytochrome c 
(both from Mann Research Laboratories, New York, N. Y.), and glucagon (Eli Lilly and Co., 
Indianapolis, Ind.). 
Enzyme Stndies.--CrystaiYlzed  trypsin and chromatographically purified soybean trypsin 
inhibitor were products of Mann Research Laboratories. Each was dissolved in phosphate- 
buffered saline (pH 7.3)  immediately" before use. Organophosphonate compounds of the type 
previously used in chemotaxis experiments (7)  and employed under a  variety of experimental 
conditions in which inhibition of serine esterases is desired  (8)  were kindly supplied by Dr. 
Elmer L. Becker (Walter Reed Army Institute of Research). The homologous phosphonate 
series  used  included  the ¢0-chloroalkyl  p-nitrophenyl ethyl  phosphonates containing alkyl 
chains of 3, 4, 5,  or 6 carbon atoms with the chloro group in the terminal carbon atom.  It is 
well known that these compounds inhibit many types of esterases, including trypsin, chymo- 
trypsin, and choline esterases, each of which has a serine atom at or near the active site of the 
enzyme (8). Heart tissue was pretreated with the appropriate phosphonate dissolved in phos- 
phate-buffered saline (pH 7.3) in a volume of 0.5 ml. After incubation at room temperature for 
20 min, tissues were diluted to 8 ml with buffered saline and washed twice before incubation 
with rat serum. 
Competitive substrate inhibition was studied  using heart  tissue, which contains a protease 
capable of hydrolyzing rat or human C3. In order to determine whether a defined  ester could 
competitively inhibit this reaction, various synthetic amino acid esters were added  with the 
substrate (consisting of purified human C3 or C3 in rat serum), mixed with heart tissue, and 
incubated at 37°C for 90 min. To provide adequate controls in this experiment, esters were 
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moved by centrlfugation, and the superuatant was tested for chemotacfic  activity. The follow- 
ing synthetic esters, obtained from Mann Research  Laboratories, New York, N. Y., were used: 
p-tosyl-L-arginine methyl ester HCI (TAMe), M.A. (Mann assayed); benzoylarginine methyl 
ester hydrochloride (BAMe), M.A.; N-acetyltyrosine ethyl ester, M.A.; glycylglycine ethyl 
ester; and glycine  ethyl ester. 
RESULTS 
Ability  of  Various  Tissues  to  Generate  Chemotactic  Activity  in  Serum.--Six 
different tissues from rats were tested for their ability to generate chemotactic 
activity in fresh autologous rat serum. In the experiments to be described, any 
activity found in untreated rat serum or in supernatants of tissue incubated in 
TABLE I 
Ability of Various Rat Tissues to Generate Chemotactic Activity in Rat Serum 
Tissue* 
Chemotactic activity$ 
Exp. A  Exp. B 
Heart  300  300 
Lung  120  35 
Kidney  0  180 
Liver  200  0 
Spleen  320  100 
Skeletal muscle  0 
* 10 mg tissue/O.1 ml normal rat serum, 37°C, for 90 min. 
:~ Chemotactic values have been corrected for background activity due to tissue by itself 
and serum by itself. 
saline was subtracted from the values obtained by incubating tissue in serum. 
In general, such control values were less than 20 % of activity found in serum 
incubated with tissue. In two different experiments it became evident that most 
tissues were capable of generating chemotactic activity in rat serum (Table I). 
There was some variability between liver and kidney from one experiment to 
the next, but in several subsequent experiments both tissues generated chemo- 
tactic activity in rat serum, kidney tending to be more active. Heart tissue has 
consistently been the most effective tissue for generation of chemotactic activity 
in serum, whereas skeletal muscle has shown little  or no ability. As a  general 
rule, it can be stated that most tissues of the rat are able to generate chemotactic 
activity in homologous serum. 
Chemotactic Activity as a Function of Dose of Heart Tissue and Rat Serum.--In 
order to define the features of this chemotactic factor-generating system, the 
amount of serum was varied, maintaining a constant reaction volume of 0.3 ml 
(phosphate-buffered saline used as necessary) with 25 mg heart tissue.  Fig.  1 
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was related to the amount of sermn used. Maximal activity was achieved at 
0.2 ml, with a drop-off in chemotactic activity when 0.3 ml serum was used. 
Fig. 2 indicates that with a constant amount of serum, the chemotactic activity 
appearing was a  function of the amount of heart tissue used,  40 rag/0.1  ml 
serum giving maximal  activity, whereas the largest dose of heart tissue  (50 
rag/0.1 ml serum) resulted in considerably less chemotactic activity. The reason 
for this reduction in activity is not known. 
Chemotactic Activity as a Function  of Duration of Incubation.--The  amount 
of chemotactic activity generated by the interaction of heart tissue with serum 
was directly related to the duration of incubation of heart tissue with rat serum 
300' 
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FIG.  1.  Chemotactic activity as a function of the amount of serum (milliliters), using 25 mg 
heart tissue in a total volume of 0.3 ml. 
at 37°C (Fig. 3, experiments A and B). Maximal activity appeared in the super- 
natant after an incubation period of 60-90 min. Shorter periods of incubation 
resulted in less activity, and prolongation of the period beyond 90 min did not 
result in additional chemotactic activity. Also shown in this figure is the ability 
of heart tissue to react with human C3 to give chemotactic activity. In this 
case, a fairly abrupt reduction in activity occurred if the period of incubation 
was  extended beyond 90 min.  The ability of C3  to substitute for serum  is 
discussed in following sections. 
Requirements of Serum in Generation of Chemotactic Activity.--In order to find 
out more about the way in which heart tissue interacted with  rat serum  to 
result  in  chemotactic  activity,  several  manipulations  were  performed.  The 
controls,  consisting  of supernatants  from heart  tissue  incubated in saline or 
serum, and serum by itself, as well as heart-serum-EDTA, are listed in Table 
II. Heating of rat serum before or after incubation with heart tissue precluded 
the appearance of, or resulted in the disappearance of, chemotactic activity. 
Compelling evidence that the chemotactic factor was related to C3 was provided 509 
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by the finding that anti-C3  (~lc-globulin)  abolished  chemotactic activity re- 
gardless of whether the antibody was added at the beginning or the end of the 
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FIG. 2.  Chemotactic activity as a function of the amount of heart tissue, with a  constant 
amount of rat serum. 0.I ml serum was tested for chemotactic activity. 
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FIG.  3.  Chemotactic  activity  as a  function  of the duration of incubation of 10 mg heart 
tissue in 0.1 m] serum or O.1 m]  (100 #g) human C3  (/~lo-g]obulin). 
enhancement in chemotactic activity indicated that conventional triggering of 
the  complement  system (requiring  the first and  the  second  components of 
complement) was not occurring. The mechanism of enhancement of chemotactic 
activity by EDTA has not been determined. It also became apparent that the 
presence of trypsin inhibitor in the system precluded generation of the chemo- 
tactic factor (Table II), suggesting the role of a proteolytic enzyme. 510  C3  LEUKOTACTIC  FACTORS PRODUCED BY  A  TISSUE PROTEASE 
Additional  evidence  that  C3  was  involved in  generation  of  chemotactic 
activity is  presented  in Table III.  Here  the  enhancing effect  of  EDTA  in 
development of  chemotactic  activity is  again seen.  Rat  serum treated  with 
TABLE II 
Conditions for Generation of Chemotactic Activity in Serum 
Preparation*  Chemotactic activity 
Heart +  saline 
Heart +  rat serum 
Rat serum 
Rat serum +  EDTA (0.02 M) 
Heart +  heated rat serum (56°C, 30 rain) 
Heart +  rat serum, then heated 
Heart +  rat serum +  50 #1 anti-rat C3 added: 
Before incubation 
After incubation 
Heart +  rat serum +  EDTA (0.02 M) 











* 20 nag heart tissue, 0.1 ml serum, incubation for 90 min at 37°C. 
TABLE III 
Evidence That C3 is Substrate .for Tissue Protease 
Preparation tested  Chemotactic activity 
Experiment A 
Heart +  saline  0 
Heart +  serum  160 
Heart +  serum +  EDTA (0.02 M)  490 
Serum  0 
Heart +  KSCN serum  0 
Heart KSCN serum +  100 #g C3  190 
Experiment B 
Heart +  50 #g C3  270 
50 #g C3  0 
Heart +  50 #g C3 +  trypsin inhibitor (50 #g)  0 
Heart +  50 #g C3 +  0.02 ~ EDTA +  trypsin inhibitor: 
At beginning  17 
At end  400 
Heart +  50 #g C5  0 
KSCN in order to inactivate C3 and C5 failed to support generation of activity 
(experiment A).  However,  the  addition of  100  gg  human C3  corrected  this 
deficiency. That  C3  alone,  but  not  C5,  was  able  to  support  generation of 
chemotactic activity is shown by experiment B,  Table III.  The  addition of 
trypsin inhibitor to the tissue-C3 mixture blocked the appearance of  chemo- JEFFREY If. HILL AND  PETER A, WARD  511 
tactic activity, as was the case when serum instead of C3 was used (Table II). 
And, just as EDTA  enhanced the amount of chemotactic activity in serum 
produced by heart tissue, it also enhanced the ability of heart tissue to generate 
chemotactic activity in purified C3. Using the heart-C3-EDTA system, trypsin 
inhibitor was effective only if added at the beginning of the incubation period. 
Little effect was found if the inhibitor was added at the end of the incubation 
time (Table III). In line with the effect of anti-C3 on chemotactic activity, the 
specificity for C3  in  the  reaction became apparent when it was found that 
incubation of human C5  (#~-globulin) with heart tissue was unproductive of 
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FIG. 4.  Dose response of chemotactic activity appearing in heart tissue-human C3  (~c- 
globulin) mixture. 
Dose Response of C3 Incubated with Heart Tissue.--Much in accord with what 
was found with rat  serum  (Fig.  1),  the amount of human C3  (/31e-globulin) 
added to heart tissue determined the amount of chemotactic activity appearing. 
In two different experiments, parallel dose-response curves were obtained (Fig. 
4,  experiments A  and B).  In experiments not reported here, kidney, spleen, 
lung,  and liver  also had  the  ability to generate chemotactic activity when 
incubated with human C3,  indicating that  this is  a  common feature of the 
tissue studied. We have also had the opportunity to study fresh human tissues 
from the various organs and have found them also to be active in generating 
chemotactic activity either in autologous serum or in purified C3. 
Identification of Chemotactic  Factor as a Split Product of C3.--The foregoing 
studies strongly suggested that the chemotactic factor generated by interaction 
of heart tissue with serum was a product of C3, possibly a  cleavage product 
produced by the action of a proteolytic enzyme in heart tissue. In order to assess 
this possibility, C3  was incubated with heart tissue (in the same manner de- 
scribed in Fig. 4), and the supernatant was subjected to analysis by gel filtration 512  C3  LEUKOTACTIC  FACTORS PRODUCED  BY A  TISSUE PROTEASE 
and ultracentrifugation. Sucrose density gradient analysis of the treated  C3 
revealed a heterogeneity of chemotactic factors produced by incubation with 
heart  (Fig.  5,  middle frame)  or  heaxt-EDTA  (Fig.  5,  bottom frame),  with 
chemotactic activity appearing in the general position determined by a  cyto- 
chrome c marker (Fig. 5, top frame) and a zone of more rapidly sedimenting 
Fro. 5. Sucrose  density gradient analysis  of human C3 treated with heart tissue, showing 
positions of chemotactic  activity (vertical  bars), C3, and protein standards. C3 was quanti- 
tated by immunoditfusion  in agar gel. 
activity which varied according to the preparation.  It also became apparent 
that the appearance of chemotactic activity could be related to reduction in the 
velocity of sedimentation of C3.  Calculations revealed a  drop in the known 
sedimentation rate of 9.5 for C3 to values between 8.5 (bottom frame of Fig. 5) 
and 7.4  (middle frame of Fig. 5).  This reduction seems to depend upon par- 
ticular conditions of the experiment and is in line with the concept that the 
chemotactic factor is a fragment split from the native C3 molecule. 
More rigorous study of the C3 cleavage products with chemotactic activity 
was  carried  out  by filtration of the  treated  C3  in  Sephadex  G-75  (Fig.  6). 
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of  chemotactic activitv  coinciding with  the  cytochrome marker  as  well  as 
activity in a  position between the bovine serum albumin and cytochrome c 
markers. Using the Andrews ulot to estimate molecular weight (9), the approxi- 
mate weights of these C3 fragments were 30,000 and 14,000. In repeated experi- 
ments of this kind,  chemot~tic activity has been found consistently in the 
vicinity of the cytochrome marker, whereas the other zone, representing a less 
retarded factor in gel filtration, has varied between the void volume and the 
Fig.  6.  Behavior of  chemotactic factors in gel filtration. Human C3 was pretreated with 
rat heart tissue, then eluted from Sephadex G-75.  Two major zones of chemotactic activity 
are present. BSA is bovine serum albumin. 
cytochrome position. Chemotactic activity has thus far not been found in a 
more retarded position (i.e. beyond the cytochrome marker). 
Characterization  of  a  Protease  in  Heart  Tissue.--It  appeared  likely that  a 
trypsin-like enzyme in heart tissue was involved in the generation of chemo- 
tactic factors from C3. In order to determine this possibility, heart tissue was 
pretreated with saline or with trypsin inhibitor or the chloroalkyl phosphonate 
series (inactivators of serine esterases), since both types of compounds would be 
expected to inhibit a trypsin-like enzyme. Mter a 20 min preincubation at room 
temperature, heart tissues were washed twice and then added to rat serum and 
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inhibitor completely blocked the ability of heart tissue to interact with serum 
and generate a  chemotactic factor.  In varying degrees,  from 55 to 100%,  the 
various chloroalkyl phosphonates also inhibited  the capacity of heart tissue to 
generate chemotactic activity in rat serum. 
Ability of Esters to Interfere with Action of Tissue Protease on C3.--It appeared 
possible to obtain information on the nature of the heart enzyme by the addition 
of amino acid esters that would compete with the  C3 substrate.  Experiments 
listed  in  Table  V  were  devised  to  test  this  possibility.  Both  rat  serum  and 
purified human C3 were used as the source of substrate,  and esters were added 
TABLE IV 
Inhibition  of a Protease in Heart Tissue by Trypsin Inhibitor and Phosphonate Compounas 
Reduction in chemotactlc 
Pretreatment of heart tissue  activity generated in rat serum 
% 
None*  0 
3-Chloroalkyl phosphonate~  94 
4-  "  "  ~  100 
5-  "  "  ~/  55 
6-  "  "  :[  78 
Trypsin inhibitor  (200 #g in 0.4 ml)  100 
* Controls included 25 nag heart tissue incubated  in saline for 20 min at room tempera- 
ture,  washed twice in saline, then incubated  in rat serum for 90 rain at 37°C. Respective 
negative control (tissue alone) and positive control (heart  +  serum) chemotactic values were 
30 and 180. 
25 mg heart tissue pretreated  with 0.4 ml 8 X  10  -4 M  phosphonate as above, then washed 
twice and incubated  with rat serum. The same protocol was followed with the trypsin in- 
hibitor. 
at either  the start or the end of the period of incubation.  Conditions included 
20 mg heart tissue,  0.1 ml ester solution (0.07 M),  and 0.1 ml rat serum or C3 
(100 #g). After incubation,  the tissue was removed by centrifugation  and the 
supernatant was tested for chemotactic activity. When necessary, the pH of the 
supernatant was adjusted to neutrality before testing for chemotactic activity. 
It was found that  esters  appropriate  to the functional  features  of an enzyme 
like trypsin  (TAMe and BAMe)  were effective inhibitors  in the generation of 
chemotactic activity, whereas  the aromatic amino acid ester N-acetyltyrosine 
ethyl ester and other esters  (glycine ethyl ester and glycylglycine ethyl ester) 
had little  or no effect. The important  control in  this  experiment,  to rule out 
nonspecific "toxic" effects of esters on cells, was the addition of ester at the end 
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inhibited the generation of chemotactic activity if added at the beginning of the 
period of incubation of tissue with substrate. N-Acetyltyrosine ethyl ester had 
inhibitory effects (36-43 %  when serum was used as the substrate)  that were 
nonspedfic; that is, the inhibition was unrelated to the period of incubation of 
tissue with substrate. When purified C3 was used as the substrate, the ester was 
ineffective regardless  of  the  time  of  addition  (Table  V).  These  results  are 
compatible with the notion that the protease in heart tissue is a  trypsin-like 
enzyme. 
TABLE V 
Inhibition  by Amino Acid Esters  of Chemotactic Factor-Generating  Capacity  of Heart  Tissue 
Ester (0.07 M) 
p-Tosyl-L-arginine  methyl ester 
Benzoylarginine  methyl ester 
N-Acetyltyrosine  ethyl ester 
Glyeine ethyl ester 
Glycylglycine  ethyl ester 
Ester added to serum  Ester added to C3 
Before*  Alter  Before*  After 
% inhibition  % inhibition 
90  0  64  0 
79  0  91  0 
43  36  0  0 
0  7  0  0 
0  0  9  0 
*  "Before"  and "after" refer to the presence of ester during the 90 min incubation period 
at 37°C. 
DISCUSSION 
These results seem to establish clearly that many tissues cangenerate chemo- 
tactic activity in serum and that, at least in the case of heart tissue, this involves 
an interaction between C3  and a  tissue-contained, trypsin-like enzyme. The 
interaction of the protease and C3 results in the production of C3 fragmentation 
products with chemotactic activity. The relatively large amount of tissue (mil- 
ligram quantities)  required  to  cleave  C3  probably  simply reflects the  very 
inefficient contact of enzyme with substrate. In most respects, these findings 
confirm and extend those of Hurley (1), who described an interaction between 
rat tissue and serum that resulted in chemotactic activity in vitro for neutro- 
phils. It seems quite possible that these data provide a plausible explanation for 
the development of the acute inflammatory response in mechanically injured 
tissue; namely, through the release of the tissue protease, C3 in the vicinity of 
the injured  tissue can serve  as a  substrate  for the production of phlogistic 
(leukotactic) factors. Thus, in the case of burned tissue, mechanically disrupted 
tissue, or infarcted tissue, to name a few examples, the stage would be set for 
the  induction of the  acute inflammatory response  by the  generation of  C3 
chemotactic factors. This  would provide  an  alternative explanation for the 
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their adherence ("sticking") to altered endothelium  and  subsequent  random 
migration of these cells into extravascular sites. However, in order to test the 
relevance of the hypothesis presented in this paper, it will be necessary to show 
the  release of the  protease from damaged  tissue  and  the  appearance of  C3 
fragments with chemotactic activity in the same tissue. Preliminary support- 
ing evidence for this latter point has already been obtained. 
Once again, in considering the acute inflammatory response, we come to the 
complement system as a mediator. It has previously been shown that immu- 
nological  triggering  of  the  complement  system  will  result  in  production  of 
factors with chemotactic (2,  6,  10)  as  well as vasoactive properties (11-13). 
TABLE VI 
Chematactic Factors Generated  from the Complement System 
Factor  Requirements  References 
C,56"'7  C1-C7  2, 6 
C3a  Plasmin  15 
Trypsin,* cobra venom factor  17, 14 
Tissue protease  This paper 
C5a  C1-C5  10, 16, 17 
Trypsin  17 
* Very limited activity under conditions  described  in reference. 
Increasingly apparent is the fact that the complement system contains a series 
of substrates from which several phlogistic mediators can be generated in such a 
manner that only one complement component is needed, the rest of the eight 
components being bypassed. This is true for the production of C3 or C5 ana- 
phylatoxin by trypsin (11-13) or cobra venom factor  (14),  as well as for the 
generation of chemotactic factors from C3 (15)  or C5 (16,  17). 
Table VI indicates the multiplicity of chemotactic factors capable of being 
generated from the complement system. These factors can be produc__ed either 
by sequential interaction of the complement system, resulting in C567 or a C5 
fragmentation product, or by direct interaction of a single complement compo- 
nent with an enzyme not intrinsic to the complement system, such as plasmin 
or trypsin. Quite apparent in Table VI is the multiplicity of agents capable of 
directly interacting with C3 or C5 to give a chemotactic product. As more data 
of this type accumulate, one begins to wonder if the complement system is more 
important  as a  mediator for nonimmunologically triggered events leading to 
production of phlogistic factors, rather than in its historical  (immunological) 
role. If experimental evidence can be obtained to suggest a relation between C3 
products and  the inflammatory response to  "nonspecific"  tissue  injury,  this 
would have therapeutic implications. In cases of inflammation in or around vital 
areas, such as the central nervous system, the facial, or respiratory areas, where 
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very desirable to know more about the mechanism of inflammation. The data 
presented in this report suggest one approach to the question. 
The precise identification of the trypsin-like enzyme in heart tissue awaits 
further work.  It  seemed possible  that  activated plasminogen might  be  the 
critical enzyme. However, two observations militate against this possibility. 
Kwaan and Astrup  failed to find plasmin  activity in  rat  heart  tissue  (18). 
Furthermore, the split product of C3, at least as far as human plasmin is con- 
cerned, is of a  lower molecular weight, around 6000  (15).  However,  neither 
observation rigorously precludes the possible role of plasmin. That thrombin 
might be involved in the reaction is under consideration, but no evidence so far 
completely substantiates or denies this possibility. Certainly the trypsin-like 
enzyme has properties different from the trypsin (beef) product used in prior 
experiments (17),  in which this enzyme generated little chemotactic activity 
from C3. But that the protease closely resembles trypsin from a functional point 
of view is unquestioned. Whether or not the protease active on C3 is identical 
with any more well-defined proteases in tissue is not known at this time. 
SUMMARY 
When  various  rat tissues are incubated  in homologous  serum,  a factor 
chemotactic in vitro for neutrophils is generated. The amount of chcmotactic 
activity  is  a function of duration of incubation and the quantity of heart tissue 
or serum employed.  Addition of trypsin inhibitor or antibody to the third 
component of complement  (C3) precludes generation of chemotactic  activity. 
In addition, antibody to C3 ablates chemotactic  activity  even after  its forma- 
tion. 
Purified human  C3 (/3zc-globulin)  effectively  substitutes for serum in the 
generation of  chemotactic activity  by heart tissue.  The active  product, as deter- 
mined by gel  filtration  or by ultracentrifugal  analysis  in  a sucrose  density gradi- 
ent,  appears to be a cleavage product of C3 with a molecular weight of approxi- 
mately  14,000. In addition, a larger C3 fragmentation  product varying  in 
molecular weight, depending upon experimental conditions,  is also found. 
The protease in rat heart tissue capable of cleaving C3 into chcmotactic 
fragments is a serine  esterase  with trypsin-like  properties  and can bc inhibited 
by organophophorous compounds or trypsin inhibitors.  The use of amino acid 
esters  in the manner of competitive substrate inhibition  confirms the trypsin- 
like  nature of the protease. 
The presence of a proteasc in heart,  and presumably in other normal tissues, 
capable of fragmenting C3 into  factors  with chemotactic activities  may explain 
the development  of the acute inflammatory  response when tissues are non- 
specifically injured. If true, this  would reinforce the role of the complement 
system in the mediation of nonimmunologically induced inflammation. 
Note added in proof: The recent publication of V. A. Bokisch, H. J.  Miiller-Eberhard, 
and  C. G. Cochrane  1969, J. Exp.  ]fled. 129:1109, emphasizes  the  bioacfive  frag- 
ments originating from C3 and extends the data presented in Table VI. 518  C3  LEUKOTACTIC  FACTORS  PRODUCED  BY  A  TISSUE  PROTEASE 
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